Perspective Therapeutics (CATX) Other Non-Current Assets (2011 - 2026)
Perspective Therapeutics recorded quarterly Other Non-Current Assets of $490000.0 in Q1 2026, up 0.82% quarter-over-quarter from $486000.0 in Q4 2025, and up 33.88% year-over-year from $366000.0 in Q1 2025.
Perspective Therapeutics' Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $490000.0 for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 33.88% year-over-year to $490000.0; the TTM figure through Mar 2026 stood at $490000.0 (up 33.88% YoY), while the FY2025 annual figure was $486000.0, up 20.0% from the prior year.
- Other Non-Current Assets came in at $490000.0 for Q1 2026 at Perspective Therapeutics, up from $486000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $490000.0 in Q1 2026 to a low of $182000.0 in Q1 2022.
- A 5-year average of $267000.0 and a median of $182000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and surged 122.53% in 2024, its largest moves.
- Perspective Therapeutics' Other Non-Current Assets stood at $182000.0 in 2022, then changed by 0.0% to $182000.0 in 2023, then soared by 122.53% to $405000.0 in 2024, then increased by 20.0% to $486000.0 in 2025, then grew by 0.82% to $490000.0 in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $490000.0, $486000.0, and $438000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.17 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.04 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 738.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 140.49 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 285.90 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.25 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 211.40 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | 490,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 490,000.00 |
| Dec 31, 2025 | 486,000.00 |
| Sep 30, 2025 | 438,000.00 |
| Mar 31, 2025 | 366,000.00 |
| Dec 31, 2024 | 405,000.00 |
| Jun 30, 2024 | 182,000.00 |
| Mar 31, 2024 | 182,000.00 |
| Dec 31, 2023 | 182,000.00 |
| Sep 30, 2023 | 182,000.00 |
| Jun 30, 2023 | 182,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Dec 31, 2022 | 182,000.00 |
| Sep 30, 2022 | 182,000.00 |
| Jun 30, 2022 | 182,000.00 |
| Mar 31, 2022 | 182,000.00 |
| Dec 31, 2021 | 182,000.00 |
| Sep 30, 2021 | 182,000.00 |
| Jun 30, 2021 | 130,000.00 |
| Mar 31, 2021 | 182,000.00 |
| Dec 31, 2020 | 182,000.00 |
| Sep 30, 2020 | 182,000.00 |
| Jun 30, 2020 | 181,000.00 |
| Mar 31, 2020 | 181,000.00 |
| Dec 31, 2019 | 181,000.00 |
| Sep 30, 2019 | 181,000.00 |
| Jun 30, 2019 | 181,000.00 |
| Mar 31, 2019 | 181,000.00 |
| Dec 31, 2018 | 181,000.00 |
| Sep 30, 2018 | 181,000.00 |
| Jun 30, 2018 | 181,000.00 |
| Mar 31, 2018 | 181,000.00 |
| Dec 31, 2017 | 181,000.00 |
| Sep 30, 2017 | 181,000.00 |
| Jun 30, 2017 | 181,000.00 |
| Mar 31, 2017 | 267,000.00 |
| Dec 31, 2016 | 181,000.00 |
| Sep 30, 2016 | 292,000.00 |
| Jun 30, 2016 | 181,000.00 |
| Mar 31, 2016 | 181,368.00 |
| Dec 31, 2015 | 233,011.00 |
| Jun 30, 2015 | 245,031.00 |
| Jun 30, 2014 | 40,320.00 |
| Mar 31, 2014 | 258,619.00 |
| Dec 31, 2013 | 181,181.00 |
| Sep 30, 2013 | 181,167.00 |
| Jun 30, 2013 | 276,507.00 |
| Mar 31, 2013 | 293,581.00 |
| Dec 31, 2012 | 301,074.00 |
| Sep 30, 2012 | 181,069.00 |
| Jun 30, 2012 | 181,027.00 |
| Mar 31, 2012 | 41,622.00 |
| Dec 31, 2011 | 273,245.00 |
| Sep 30, 2011 | 279,469.00 |
| Jun 30, 2011 | 73,988.00 |